Camp4 Therapeutics Corp Cash Flow Statement

Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -49.29M-51.79M
Share-based Compensation 2.91M4.03M
Gains from Investment Securities 1.40M0.36M
Cash from Operations -44.16M-45.60M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.09M0.08M
Depreciation & Amortization (CF) 1.68M1.70M
Change in Working Capital
Change in Account Payables -1.11M0.17M
Change in Accured Expenses -0.14M1.53M
Investing Activities
Capital Expenditures 0.68M0.44M
Cash from Investing Activities -0.68M-0.44M
Financing Activities
Other financing activities 3.98M
Change in Capital Stock
Shares Issued 0.18M76.35M
Misc.
Cash from Financing Activities 0.30M71.66M
Change in Cash -44.53M25.66M
Free Cash Flow -44.83M-46.04M
Net Cash Flow -44.53M25.62M